Drug
Adebrelimab
Adebrelimab: highest development phase Phase 1/2, developed by Shanghai Hengrui Pharmaceutical Co., Ltd.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Shanghai Hengrui Pharmaceutical Co., Ltd.
Trials
| Drug | Phase | Indication |
|---|---|---|
| Adebrelimab NCT05794477 | Phase 1/2 | Advanced Solid Tumor |
Latest
No recent events.
Follow Adebrelimab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.